How much has Avistone Pharmaceuticals Biotechnology raised?

Avistone Pharmaceuticals Biotechnology has raised $372.0M in total funding across its recorded rounds.

PrivateMarketView

What is Avistone Pharmaceuticals Biotechnology worth?

$628.3Mlast reported valuation · Oct 2026

Avistone Pharmaceuticals Biotechnology's last reported valuation, Mar 2025. Nothing priced has surfaced since.

See the PA Mark and its inputs on the profile →

Free account

More of Avistone Pharmaceuticals Biotechnology with a free account

·The complete investor list: 11 names
·Watch Avistone Pharmaceuticals Biotechnology: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026

▮▮

Markrounds hold their value until the next priced eventMark, today

log scale

Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Avistone Pharmaceuticals Biotechnology funding history

No rounds on record

No funding rounds for Avistone Pharmaceuticals Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Avistone Pharmaceuticals Biotechnology valuation

Avistone Pharmaceuticals Biotechnology's last reported valuation was $628 million in Mar 2025. No priced round, secondary trade or fund mark has surfaced since.

How Avistone Pharmaceuticals Biotechnology's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Avistone Pharmaceuticals Biotechnology, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Avistone Pharmaceuticals Biotechnology

What is Avistone Pharmaceuticals Biotechnology worth?: Avistone Pharmaceuticals Biotechnology is valued at $628.3M as of Oct 2026. Avistone Pharmaceuticals Biotechnology's last reported valuation, Mar 2025. Nothing priced has surfaced since.
How much has Avistone Pharmaceuticals Biotechnology raised?: Avistone Pharmaceuticals Biotechnology has raised $372.0M in total funding across its recorded rounds.